Skip to main content
Log in

IL-2 signals through Sgk1 and inhibits proliferation and apoptosis in kidney cancer cells

  • Original Article
  • Published:
Journal of Molecular Medicine Aims and scope Submit manuscript

Abstract

The interleukin-2 is a cytokine that is essential for lymphocytic survival and function. Ectopic expression of the IL-2 receptor in epithelial tissues has been reported previously, although the functional significance of this expression is still being investigated. We provided novel structural and functional information on the expression of the IL-2 receptor in kidney cancer cells and in other normal and neoplastic human epithelial tissues. In A-498 kidney cancer cells, we showed that IL-2 binding to its own receptor triggers a signal transduction pathway leading to the inhibition of proliferation and apoptosis. We found that the inhibition of proliferation is associated with Erk1/2 dephosphorylation, whereas the survival signals appear to be mediated by Sgk1 activation. This investigation focuses on the IL-2 induced regulation of Sgk1 and describes a role of the IL-2 receptor and Sgk1 in the regulation of epithelial tumor cell death and survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

Abbreviations

IL-2:

Interleukin-2

IL-2R:

Interleukin-2 Receptor

Sgk1:

Serum and glucocorticoid regulated kinase

Erk1/2:

Extracellular regulated kinase 1/2

Shc-1:

Src homology 2 domain containing

References

  1. David D, Bani L, Moreau JL, Treilhou MP, Nakarai T, Joussemet M, Ritz J, Dupont B, Pialoux G, Theze J (1998) Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapy. Proc Natl Acad Sci USA 95:11348–11353

    Article  PubMed  CAS  Google Scholar 

  2. Upton MP, Parker RA, Youmans A, McDermott DF, Atkins MB (2005) Histologic predictors of renal cell carcinoma response to interleukin-2-based therapy. J Immunother 28:488–495

    Article  PubMed  CAS  Google Scholar 

  3. Bazan JF (1992) Unraveling the structure of IL-2. Science 257:410–412

    Article  PubMed  CAS  Google Scholar 

  4. Kelly E, Won A, Refaeli Y, Van Parijs L (2002) IL-2 and related cytokines can promote T cell survival by activating AKT1. J Immunol 168:597–603

    PubMed  CAS  Google Scholar 

  5. Brunet A, Park J, Tran H, Hu LS, Hemmings BA, Greenberg ME (2001) Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol 21:952–965

    Article  PubMed  CAS  Google Scholar 

  6. Kobayashi T, Cohen P (1999) Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2. Biochem J 339:319–328

    Article  PubMed  CAS  Google Scholar 

  7. Perrotti N, He RA, Phillips SA, Haft CR, Taylor SI (2001) Activation of serum-and glucocorticoid-induced protein kinase (Sgk) by cyclic AMP and insulin. J Biol Chem 276:9406–9412

    Article  PubMed  CAS  Google Scholar 

  8. Frodin M, Antal TL, Dummler BA, Jensen CJ, Deak M, Gammeltoft S, Biondi RM (2002) A phosphoserine/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation. EMBO J 21:5396–5407

    Article  PubMed  Google Scholar 

  9. Menniti M, Iuliano R, Amato R, Boito R, Corea M, Le Pera I, Gulletta E, Fuiano G, Perrotti N (2005) Serum and glucocorticoid-regulated kinase Sgk1 inhibits insulin-dependent activation of phosphomannomutase 2 in transfected COS-7 cells. Am J Physiol Cell Physiol 288:C148–C155

    PubMed  CAS  Google Scholar 

  10. Leong ML, Maiyar AC, Kim B, O’Keeffe BA, Firestone GL (2003) Expression of the serum- and glucocorticoid-inducible protein kinase, Sgk, is a cell survival response to multiple types of environmental stress stimuli in mammary epithelial cells. J Biol Chem 278:5871–5882

    Article  PubMed  CAS  Google Scholar 

  11. Maiyar AC, Huang AJ, Phu PT, Cha HH, Firestone GL (1996) p53 stimulates promoter activity of the sgk. serum/glucocorticoid-inducible serine/threonine protein kinase gene in rodent mammary epithelial cells. J Biol Chem 271:12414–12422

    Article  PubMed  CAS  Google Scholar 

  12. Wu W, Chaudhuri S, Brickley DR, Pang D, Karrison T, Conzen SD (2004) Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer Res 64:1757–1764

    Article  PubMed  CAS  Google Scholar 

  13. Zheng, Li D-C, Zhang Z-D, Zhao J, Ge J-F (2005) Anti-gastric cancer active immunity induced by FasL/B7-1gene-modified tumor cells. World J Gastroenterol 11:3204–3211:1757–1764

    PubMed  CAS  Google Scholar 

  14. Suminami Y, Kashii Y, Law JC, Lin WC, Stanson J, Reichert TE, Rabinowich H, Whiteside TL (1988) Molecular analysis of the IL-2 receptor beta chain gene expressed in human tumor cells. Oncogene 16:1309–1317

    Article  CAS  Google Scholar 

  15. Christoffersen CT, Bornefeldt KE, Rotella CM, Gonzales N Vissing H, Shymko RM, Hoeve JT, Groffen J, Heisterkamp N, De Meyts P (1994) Negative cooperativity in the insulin-like growth factor-I receptor and a chimeric IGF-I/insulin receptor. Endocrinology 1:472–475

    Article  Google Scholar 

  16. Shikama Y, U M, Miyashita T, Yamada M (2001) Comprehensive studies on subcellular localization and cell death inducing activities of eight GFP-tagged apoptosis related caspase. Exp Cell Res 264:315–325

    Article  PubMed  CAS  Google Scholar 

  17. Waldegger S, Barth P, Raber G, Lang F (1997) Cloning and characterization of a putative human serine/threonine protein kinase transcriptionally modified during anisotonic and isotonic alterations of cell volume. Proc Natl Acad Sci USA 94:4440–4445

    Article  PubMed  CAS  Google Scholar 

  18. Schimpl A, Berberich I, Kneitz B, Kramer S, Santner-Nanan B, Wagner S, Wolf M, Hunig T (2002) IL-2 and autoimmune disease. Cytokine Growth Factor Rev 13:369–378

    Article  PubMed  CAS  Google Scholar 

  19. Lesur O, Brisebois M, Thibodeau A, Chagnon F, Lane D, Fullop T (2004) Role of IFN-gamma and IL-2 in rat lung epithelial cell migration and apoptosis after oxidant injury. Am J Physiol Lung Cell Mol Physiol 286:L4–L14

    Article  PubMed  CAS  Google Scholar 

  20. Fukushima K, Hara-Kuge S, Ideo H, Yamashita K (2001) Carbohydrate recognition site of interleukin-2 in relation to cell proliferation. J Biol Chem 276:31202–31208

    Article  PubMed  CAS  Google Scholar 

  21. Sharon M, Siegel JP, Tosato G, Yodoi J, Gerrard TL, Leonard WJ (1988) The human interleukin 2 receptor beta chain (p70). Direct identification, partial purification, and patterns of expression on peripheral blood mononuclear cells. J Exp Med 167:1265–1270

    Article  PubMed  CAS  Google Scholar 

  22. Weissman AM, Harford JB, Svetlik PB, Leonard WL, Depper JM, Waldmann TA, Greene WC, Klausner RD (1986) Only high-affinity receptors for interleukin 2 mediate internalization of ligand. Proc Natl Acad Sci USA 83:1463–1466

    Article  PubMed  CAS  Google Scholar 

  23. Wang Xi, Rickert M, Garcia KC (2005) Structure of the quaternary complex of interleukin-2 with its, ß, and χc receptors. Science 310:1159–1163

    Article  PubMed  CAS  Google Scholar 

  24. Kradin RL, Xia W, Pike M, Byers HR, Pinto C (1996) Interleukin-2 promotes the motility of dentric cells and their accumulation in lung and skin. Pathobiology 64:180–186

    Article  PubMed  CAS  Google Scholar 

  25. Thèze J, Alzari PM, Bortoglio J (1996) Intereleukin 2 and its receptor recent advances and new immunological functions. Immunol Today 17:481–484

    Article  PubMed  Google Scholar 

  26. Reinecker HC, Podolsky D (1995) Human intestinal epithelial cells express functional cytokine receptor sharing the common γc chain oh the IL-2 receptor. Proc Natl Acad Sci USA 92:8353–8357

    Article  PubMed  CAS  Google Scholar 

  27. McMillian DN, Kernohan NM, Flett ME, Heys SD, Deehan DJ, Sewell HF, Walker F, Eremin O (1995) Interleukin-2 receptor expresion in human solid tumor cells in situ and in vitro: evidence for a direct role in regulation of tumor cell proliferation. Int J Cancer 60:766–772

    Article  Google Scholar 

  28. Vamosi G, Bodnar A, Vereb G, Jenei A, Goldman CK, Langowski J, Toth K, Matyus L, Szollosi J, Waldmann TA, Damjanovich S (2004) IL-2 and IL-15 receptor alpha-subunits are coexpressed in a supramolecular receptor cluster in lipid rafts of T cells. Proc Natl Acad Sci USA 101:11082–11087

    Article  PubMed  CAS  Google Scholar 

  29. Robb RJ, Greene WC, Rusk CM (1984) Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen. J Exp Med 160:1126–1146

    Article  PubMed  CAS  Google Scholar 

  30. Gesbert F, Sauvonnet N, Dautry-Varsat A (2004) Clathrin-independent endocytosis and signalling of interleukin 2 receptors IL-2R endocytosis and signalling. Curr Top Microbiol Immunol 286:119–148

    PubMed  CAS  Google Scholar 

  31. Morrone G, Bond HM, Cuomo C, Agosti V, Petrella A, Pagnano AM, Della Corte A, Marasco O, Venuta S (1995) Differential regulation of the expression of interleukin-2 receptor gamma-chain during the in vitro differentiation of human myeloid cells. Biochem J 308:909–914

    PubMed  CAS  Google Scholar 

  32. Romerio F, Zella D (2002) MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b. FASEB J 16:1680–1682

    PubMed  CAS  Google Scholar 

  33. Faletti CJ, Perrotti N, Taylor SI, Blazer-Yost BL (2002) sgk: an essential convergence point for peptide and steroid hormone regulation of ENaC-mediated Na+ transport. Am J Physiol Cell Physiol 282:C494–C500

    PubMed  CAS  Google Scholar 

  34. Sakoda H, Gotoh Y, Katagiri H, Kurokawa M, Ono H, Onishi Y, Anai M, Ogihara T, Fujishiro M, Fukushima Y, Abe M, Shojima N, Kikuchi M, Oka Y, Hirai H, Asano T (2003) Differing roles of Akt and serum and glucocorticoid-regulated kinase in glucose metabolism, DNA synthesis, and oncogenic activity. J Biol Chem 278:25802–25807

    Article  PubMed  CAS  Google Scholar 

  35. Vallon V, Lang F (2005) New insights into the role of serum- and glucocorticoid-inducible kinase SGK1 in the regulation of renal function and blood pressure. Curr Opin Nephrol Hypertens 14:59–66

    Article  PubMed  CAS  Google Scholar 

  36. Rauhala HE, Porkka KP, Tolonen TT, Martikainen PM, Tammela TL, Visakorpi T (2005) Dual-specificity phosphatase 1 and serum/glucocorticoid-regulated kinase are downregulated in prostate cancer. Int J Cancer 117:738–745

    Article  PubMed  CAS  Google Scholar 

  37. Biondi RM, Kieloch A, Currie RA, Deak M, Alessi DR (2001) The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB. EMBO J 20:4380–4390

    Article  PubMed  CAS  Google Scholar 

  38. Lang F, Cohen P (2001) Regulation and physiological roles of serum- and glucocorticoid-induced protein kinase isoforms. Science’s Signal Transduct Knowledge Environment 108:RE17

    Google Scholar 

  39. Park J, Leong ML, Buse P, Maiyar AC, Firestone GL, Hemmings BA (1999) Serum and glucocorticoid-inducible kinase (SGK) is a target of the PI 3-kinase-stimulated signaling pathway. EMBO J 18:3024–3033

    Article  PubMed  CAS  Google Scholar 

  40. Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB, Cohen P (1997) Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha. Curr Biol 7:261–269

    Article  PubMed  CAS  Google Scholar 

  41. Lens SM, Kataoka T, Fortner KA, Tinel A, Ferrero I, MacDonald RH, Hahne M, Beermann F, Attinger A, Orbea HA, Budd RC, Tschopp J (2002) The caspase 8 inhibitor c-FLIP(L) modulates T-cell receptor-induced proliferation but not activation-induced cell death of lymphocytes. Mol Cell Biol 22:5419–5433

    Article  PubMed  CAS  Google Scholar 

  42. Boehrer S, Kukoc-Zivojnov N, Nowak D, Bergmann M, Baum C, Puccetti E, Weidmann E, Hoelzer D, Mitrou PS, Chow KU (2004) Upon drug-induced apoptosis expression of prostate-apoptosis-response-gene-4 promotes cleavage of caspase-8, bid and mitochondrial release of cytochrome c. Hematology 9:425–431

    Article  PubMed  CAS  Google Scholar 

  43. Chen JS, Konopleva M, Andreeff M, Multani AS, Pathak S, Mehta K (2004) Drug-resistant breast carcinoma (MCF-7) cells are paradoxically sensitive to apoptosis. J Cell Physiol 200:223–234

    Article  PubMed  CAS  Google Scholar 

  44. Wu XX, Kakehi Y, Mizutani Y, Kamoto T, Kinoshita H, Isogawa Y, Terachi T, Ogawa O (2002) Doxorubicin enhances TRAIL-induced apoptosis in prostate cancer. Int J Oncol 20:949–954

    PubMed  CAS  Google Scholar 

  45. Tangir J, Bonafe N, Gilmore-Hebert M, Henegariu O, Chambers SK (2004) SGK1, a potential regulator of c-fms related breast cancer aggressiveness. Clin Exp Metastasis 21:477–483

    Article  PubMed  CAS  Google Scholar 

  46. Buse P, Tran SH, Luther E, Phu PT, Aponte GW, Firestone GL (1999) Cell cycle and hormonal control of nuclear-cytoplasmic localization of the serum- and glucocorticoid-inducible protein kinase, Sgk, in mammary tumor cells. A novel convergence point of anti-proliferative and proliferative cell signaling pathways. J Biol Chem 274:7253–7263

    Article  PubMed  CAS  Google Scholar 

  47. Waldegger S, Klingel K, Barth P, Sauter M, Rfer ML, Kandolf R, Lang F (1999) h-sgk serine-threonine protein kinase gene as transcriptional target of transforming growth factor beta in human intestine. Gastroenterology 116:1081–1088

    Article  PubMed  CAS  Google Scholar 

  48. Li W, Wang S, Chen C, Zhuang G (2006) Induction of tumor cell apoptosis via Fas/DR5. Cell Mol Immunol 3:467–471

    PubMed  CAS  Google Scholar 

  49. Schickling O, Stegh AH, Byrd J, Peter ME (2001) Nuclear localization of DEDD leads to caspase-6 activation through its death effector domain and inhibition of RNA polymerase I dependent transcription. Cell Death Differ 8:1157–1168

    Article  PubMed  CAS  Google Scholar 

  50. Ferrando-May E (2005) Nucleocytoplasmic transport in apoptosis. Cell Death Differ 12:1236–1276

    Article  CAS  Google Scholar 

  51. Besnault-Mascard L, Leprince C, Auffredou MT, Meunier B, Bourgeade MF, Camonis J, Lorenzo HK, Vazquez A (2005) Caspase-8 sumoylation is associated with nuclear localization. Oncogene 24:3268–3273

    Article  PubMed  CAS  Google Scholar 

  52. Nelson BH, Martyak TP, Thompson LJ, Moon JJ, Wang T (2003) Uncoupling of promitogenic and antiapoptotic functions of IL-2 by Smad-dependent TGF-beta signaling. J Immunol 170:5563–5570

    PubMed  CAS  Google Scholar 

  53. Aoyama T, Matsui T, Novikov M, Park J, Hemmings B, Rosenzweig A (2005) Serum and glucocorticoid-responsive kinase-1 regulates cardiomyocyte survival and hypertrophic response. Circulation 111:1652–1659

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We thank Charity Nofziger and Professor Bonnie Blazer-Yost for critical reading and helpful discussion of the manuscript, and Nicola Amodio for the caspase 8 confocal experiment’s acquisition.

This work was supported by Fondazione Carical, Cluster 04 work package 6A, Cofin 2003/20032003063143_003, Cofin 2005 /068017_004, Interlink II04C0G4EM.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nicola Perrotti.

Additional information

In loving memory of Salvatore Venuta, 1944–2007.

Electronic supplementary material

Below is the link to the electronic supplementary material.

109_2007_205_MOESM1_ESM.doc

Rights and permissions

Reprints and permissions

About this article

Cite this article

Amato, R., Menniti, M., Agosti, V. et al. IL-2 signals through Sgk1 and inhibits proliferation and apoptosis in kidney cancer cells. J Mol Med 85, 707–721 (2007). https://doi.org/10.1007/s00109-007-0205-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00109-007-0205-2

Keywords

Navigation